IPO Boutique

Immunome Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...



For IPO Boutique's "scale of 1 to 5" BUY rating on Immunome Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Immunome Inc.IMNM -
NASDAQ
$11.00-$13.00 $12.00 $15.663.25 million10/2/2020
Ladenburg Thalmann, Chardan
Co-Manager(s):
Health Care
Filing(s):

Terms Added 2020-09-24



Immunome Inc. Quote & Chart - Click for current quote - IMNM

About Immunome Inc. (adapted from Immunome Inc. prospectus):
They are a biopharmaceutical company utilizing our proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "IMNM" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved